Article Details
Retrieved on: 2018-01-11 23:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Christopher Shackelton decreased its stake in Bioscrip Inc (BIOS) by 66.4% based on its latest 2017Q3 regulatory filing with the SEC. Coliseum Capital Management Llc sold 3.73M shares as the company's stock rose 8.97% with the market. The hedge fund run by Christopher Shackelton held 1.89M ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here